Create Account
D
ANI Pharmaceuticals, Inc. ANIP
$44.67 -$0.54-1.19%
Recommendation
Sell
Prev Close
$44.67
Volume
70,522
Avg Vol (90D)
66,354
Market Cap
$728.29M
Dividend & Yield
--
52-Week Range
$22.31 - $45.50
P/E (TTM)
--
EPS (TTM)
-$4.49
My Lists My Alerts
Report
Rating
Reward
D+
Weak
Risk
D
Weak
Rating Factors
Growth Index
Weak
Efficiency Index
--
Solvency Index
Good
Total Return Index
Fair
Volatility Index
Weak
Dividend Index
--
Headlines
ANI Pharmaceuticals (ANIP, $42.98) Moving Average Convergence Divergence (MACD) Histogram turned positive on January 23, 2023
1/24/2023 - Tickeron - Technical Analysis
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Sees Large Drop in Short Interest
1/22/2023 - Zolmax
ANI Pharmaceuticals (ANIP, $42.02) Moving Average Convergence Divergence (MACD) Histogram turned negative on January 20, 2023
1/21/2023 - Tickeron - Technical Analysis
ANI Pharmaceuticals (NASDAQ:ANIP) Shares Up 10.3%
1/11/2023 - Zolmax
ANI Pharmaceuticals (NASDAQ:ANIP) Stock Price Up 10.3%
1/11/2023 - Ticker Report
ANI Pharmaceuticals (ANIP, $42.25) RSI Indicator left the overbought zone on January 09, 2023
1/10/2023 - Tickeron - Stocks
ANIP Crosses Above Average Analyst Target
1/9/2023 - ETF Channel
Insiders See US$752k Investment In ANI Pharmaceuticals Jump Last Week
1/8/2023 - Simply Wall St
ANI Pharmaceuticals (ANIP, $43.92) Moving Average Convergence Divergence (MACD) Histogram turned positive on January 6, 2023
1/7/2023 - Tickeron - Technical Analysis
ANI Pharmaceuticals (ANIP, $43.92) price may drop as it broke higher Bollinger Band on Jan 06, 2023
1/7/2023 - Tickeron - Stocks
ANI Pharmaceuticals (ANIP, $43.92) RSI Indicator left the overbought zone on January 06, 2023
1/7/2023 - Tickeron - Stocks
ANI Pharmaceuticals (ANIP, $39.35) Moving Average Convergence Divergence (MACD) Histogram turned negative on January 4, 2023
1/5/2023 - Tickeron - Stocks
2023 A Big Year For Testosterone: AbbVie And ANI Pharmaceuticals Best Positioned To Benefit
1/1/2023 - Seeking Alpha - Long Ideas
ANI Pharmaceuticals (ANIP, $40.93) Moving Average Convergence Divergence (MACD) Histogram turned positive on December 29, 2022
12/30/2022 - Tickeron - Stocks
ANI Pharmaceuticals (NASDAQ:ANIP) Sees Unusually-High Trading Volume
12/29/2022 - Ticker Report
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Short Interest Update
12/20/2022 - Zolmax
ANI Pharmaceuticals gets FDA approval for generic levocarnitine tablets
12/19/2022 - SeekingAlpha.com: All News
ANI Pharmaceuticals Announces the FDA Approval and Launch of Levocarnitine Tablets USP
12/19/2022 - Business Wire
ANI Pharmaceuticals (NASDAQ:ANIP) Sees Unusually-High Trading Volume
12/3/2022 - Zolmax
ANI Pharmaceuticals (ANIP, $38.83) Moving Average Convergence Divergence (MACD) Histogram turned negative on December 2, 2022
12/3/2022 - Tickeron - Stocks
ANI Pharmaceuticals Announces the FDA Approval and Launch of Fluoxetine Oral Solution USP
11/28/2022 - Business Wire
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Shares Sold by Brandywine Global Investment Management LLC
11/27/2022 - Ticker Report
Martingale Asset Management L P Boosts Stock Position in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)
11/23/2022 - Zolmax
ANI Pharmaceuticals (ANIP, $39.56) Moving Average Convergence Divergence (MACD) Histogram turned positive on November 18, 2022
11/19/2022 - Tickeron - Stocks
Kennedy Capital Management Inc. Acquires New Shares in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)
11/17/2022 - Ticker Report
Income Statement
Total Revenue (TTM)
$283.08M
EBITDA (TTM)
$16.52M
EBIT (TTM)
-$41.25M
Net Income (TTM)
-$67.79M
Balance Sheet
Total Assets (Q)
$739.11M
Total Debt (Q)
$287.61M
Total Liabilities (Q)
$402.44M
Book Value Per Share (Q)
$19.11
Cash Flow
Cash from Operations (TTM)
-$38.99M
Cash from Investing (TTM)
-$94.81M
Cash from Financing (TTM)
$174.83M
Net Change in Cash (TTM)
$41.03M
Filings
Filing Date
Wednesday, November 9, 2022
Period Date
Friday, September 30, 2022
Next Filing
Week of Mar 13 and 17 (est)
Price History
Loading...
Beta
0.93
7-Day Total Return
2.62%
30-Day Total Return
12.58%
60-Day Total Return
16.75%
90-Day Total Return
43.63%
Year to Date Total Return
11.56%
1-Year Total Return
16.42%
2-Year Total Return
46.65%
3-Year Total Return
-28.38%
5-Year Total Return
-23.65%
52-week Low
Jun 16, 2022 - $22.31
52-week High
Feb 01, 2023 - $45.50
Valuation
Market Cap
$728.29M - Small Cap
Enterprise Value
$984.47M
Price/Sales (TTM)
2.57
Price/Book (Q)
2.34
Dividends and Shares
Shares Outstanding
16.30M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.anipharmaceuticals.com
Phone Number
218 634 3500
Address
210 Main Street West
Baudette, MN 56623
Country
United States
Year Founded
2001
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on... more
NASDAQ 02/03/2023 4:00PM Eastern Quotes delayed
Weiss Ratings